Skip to content

Clinical trials

Phase 2 Fibrosis trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Fibrosis Phase: Phase 2 Clear all

157 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20018
20021
20034
20044
20054
20062
20075
20085
20097
20105
20116
20129
201311
20145
20153
201610
20175
20184
20194
20204
20218
20225
20238
20248
202513
20265

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed84
Recruiting22
Terminated22
Unknown status13
Active, not recruiting8
Withdrawn4
Not yet recruiting2
Suspended1
Enrolling by invitation1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)14
Gilead Sciences11
Hospital Clinic of Barcelona4
Assistance Publique - Hôpitaux de Paris3
Conatus Pharmaceuticals Inc.3
Genfit3
Novartis Pharmaceuticals3
Celgene2
Hunter Holmes Mcguire Veteran Affairs Medical Center2
InSilico Medicine Hong Kong Limited2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Fibrosis157
Non-alcoholic Fatty Liver Disease21
Liver Cirrhosis16
Hypertension, Portal15
Hepatitis C14
Liver Diseases14
Ascites13
Hepatic Encephalopathy12
Idiopathic Pulmonary Fibrosis12
Fatty Liver10

Trials

Showing 51 to 75 of 157. Each trial links to its page on Pharma Observatory.

57 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.